. Age versus comorbidities as
risk factors for complications after elective abdominal
aortic reconstructive surgery. J Vasc Surg 2001;33:345-52.
145. Dardik A, Lin JW, Gordon TA, Williams GM, Perler BA. Results
of elective abdominal aortic aneurysm repair in the 1990s: a
population-based analysis of 2335 cases. J Vasc Surg
1999;30:985-95.
146. Treiman GS, Treiman RL, Foran RF, Cossman DV, Cohen JL,
Levin PM, et al. The inﬂuence of diabetes mellitus on the
risk of abdominal aortic surgery. Am Surg 1994;60:436-40.
147. Axelrod DA, Upchurch GR Jr, DeMonner S, Stanley JC,
Khuri S, Daley J, et al. Perioperative cardiovascular risk
stratiﬁcation of patients with diabetes who undergo elective major vascular surgery. J Vasc Surg 2002;35:894-901.
148. Leurs LJ, Laheij RJ, Buth J. Inﬂuence of diabetes mellitus on
the endovascular treatment of abdominal aortic aneurysms. J Endovasc Ther 2005;12:288-96.
149. FDA Drug Safety Communication. FDA revises warnings
regarding use of the diabetes medicine metformin in
certain patients with reduced kidney function. Available at:
https://www.fda.gov/Drugs/DrugSafety/ucm493244.htm.
Accessed April 2017.
150. Baerlocher MO, Asch M, Myers A. Five things to know
about.metformin and intravenous contrast. CMAJ
2013;185:E78.
151. Milne AA, Adam DJ, Murphy WG, Ruckley CV. Effects of
asymptomatic abdominal aortic aneurysm on the soluble
coagulation system, platelet count and platelet activation.
Eur J Vasc Endovasc Surg 1